Picture of ConvaTec logo

CTEC ConvaTec News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG-Convatec Group PLC Convatec Group PLC: Total Voting Rights

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC: Total Voting Rights

   31-May-2023 / 10:06 GMT/BST

   ══════════════════════════════════════════════════════════════════════════

   31 May 2023

                               Convatec Group Plc
                         ("Convatec" or "the Company")

                              Total Voting Rights

   The following notification  is made  in accordance with  the UK  Financial
   Conduct Authority's Disclosure and Transparency  Rule 5.6.1. As at 31  May
   2023, the  Company's  issued  capital  with  voting  rights  consisted  of
   2,045,589,597 ordinary shares of 10p each (“Shares”). The Company does not
   hold any Shares in Treasury at the date of this disclosure.

   The above  figure  (2,045,589,597) can  be  used by  shareholders  as  the
   denominator for  the  calculations  by  which to  determine  if  they  are
   required to notify their  interest in, or a  change to, their interest  in
   the Company  under the  UK Financial  Conduct Authority's  Disclosure  and
   Transparency Rules. 

    

   Enquiries

    

   Grace McCalla, Assistant Company
   Secretary                                            +44(0)7575353388

    

   Cosec@convatec.com 

    

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92

    

   About Convatec

    

   Pioneering trusted medical solutions to improve the lives we touch:
   Convatec is a global medical products and technologies company, focused on
   solutions for the management of chronic conditions, with leading positions
   in advanced wound care, ostomy care, continence and critical care, and
   infusion care. With around 10,000 colleagues, we provide our products and
   services in almost 100 countries, united by a promise to be forever
   caring. Our solutions provide a range of benefits, from infection
   prevention and protection of at-risk skin, to improved patient outcomes
   and reduced care costs. Group revenues in 2022 were over $2 billion. The
   company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more
   about Convatec, please visit http://www.convatecgroup.com.

    

   ══════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: TVR
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  247622
   EQS News ID:   1645963


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    1 fncls.ssp?fn=show_t_gif&application_id=1645963&application_name=news&site_id=reuters9

References

   Visible links


============

Recent news on ConvaTec

See all news